Semaglutide is a drug that stimulates insulin production and can help manage weight. It belongs to a group of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. It’s the main ingredient ...

A once-weekly, 2.4-mg dose of subcutaneous semaglutide, a glucagon-like peptide-1 receptor agonist, is used to treat obesity in adults, but assessment of the drug in adolescents has been lacking. In ...

Semaglutide is the active ingredient in certain brand-name medications prescribed for obesity, type 2 diabetes, and more. Semaglutide belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist ...

Semaglutide is a drug used for type 2 diabetes, weight loss, and more. Oral tablets and injections are both effective ways to take semaglutide. Oral tablets do not require the use of needles, but you ...

Compounded semaglutide is semaglutide that a person has chemically altered or mixed with one or more other drugs. The Food and Drug Administration (FDA) does not approve the safety or effectiveness of ...

*Please mention the European Congress on Obesity when using this story* New research being presented at the European Congress on Obesity (ECO) in Venice, Italy (12-15 May) has explored the benefits of ...

Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to reduce the risk of adverse cardiovascular events in patients with diabetes. Whether semaglutide can reduce cardiovascular ...

The diabetes and weight loss drug semaglutide is a popular and powerful treatment option. While the injectable forms, Ozempic and Wegovy, have gotten plenty of coverage, there’s been much less hype ...

The STEP UP trials revealed that a 7.2 mg dose of semaglutide led to greater weight loss than the currently approved 2.4 mg dose. Nearly half of participants lost 20% or more of their body weight, ...

Study reveals semaglutide’s potential in lowering elevated urine albumin levels in overweight chronic kidney disease patients. Study: Semaglutide in patients with overweight or obesity and chronic ...